UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Automatic anomaly detection in engineering diagrams using machine learning

Korean Journal of Chemical Engineering, 2023, 40(11), 284, pp.2612-2623

2023

Volltextzugriff (PDF)

Variation in Summer Surface Air Temperature over Northeast Asia and Its Associated Circulation Anomalies

Advances in atmospheric sciences, 2016, Vol.33 (1), p.1-9

2016

Volltextzugriff (PDF)

Poor prognostic impact of high serum ferritin levels in patients with a lower risk of diffuse large B cell lymphoma

International journal of hematology, 2020-04, Vol.111 (4), p.559-566

2020

Volltextzugriff (PDF)

Autologous stem cell transplantation in elderly patients with multiple myeloma in Korea: the KMM1807 study

International journal of hematology, 2020-07, Vol.112 (1), p.84-95

2020

Volltextzugriff (PDF)

Real-world toxicity and effectiveness of ixazomib, lenalidomide, and dexamethasone in Korean patients with relapsed and/or refractory multiple myeloma

International journal of hematology, 2023-02, Vol.117 (2), p.225-235

2023

Volltextzugriff (PDF)

Pegteograstim prophylaxis for chemotherapy-induced neutropenia and febrile neutropenia: a prospective, observational, postmarketing surveillance study in Korea

Supportive care in cancer, 2021-09, Vol.29 (9), p.5383-5390

2021

Volltextzugriff (PDF)

Clinical significance of metabolic tumor volume by PET/CT in stages II and III of diffuse large B cell lymphoma without extranodal site involvement

Annals of hematology, 2012-05, Vol.91 (5), p.697-703

2012

Volltextzugriff (PDF)

Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone

International journal of hematology, 2021, Vol.113 (1), p.81-91

2021

Volltextzugriff (PDF)

Phase II study of safety and efficacy of BEB (bendamustine, etoposide, and busulfan) conditioning regimen for autologous stem cell transplantation in non-Hodgkin lymphoma

Annals of hematology, 2020-04, Vol.99 (4), p.819-828

2020

Volltextzugriff (PDF)

Efficacy and safety of blinatumomab treatment in adult Korean patients with relapsed/refractory acute lymphoblastic leukemia on behalf of the Korean Society of Hematology ALL Working Party

Annals of hematology, 2019-01, Vol.98 (1), p.151-158

2019

Volltextzugriff (PDF)

A risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score

European journal of nuclear medicine and molecular imaging, 2018-12, Vol.45 (13), p.2274-2284

2018

Volltextzugriff (PDF)

Clinical features and treatment outcomes of limited-stage mantle cell lymphoma: Consortium for Improving Survival of Lymphoma report

Annals of hematology, 2020-02, Vol.99 (2), p.223-228

2020

Volltextzugriff (PDF)

Different prognostic effects of core-binding factor positive AML with Korean AML registry data

Annals of hematology, 2019-05, Vol.98 (5), p.1135-1147

2019

Volltextzugriff (PDF)

Venous thromboembolism in relapsed or refractory multiple myeloma patients treated with lenalidomide plus dexamethasone

International journal of hematology, 2019-01, Vol.109 (1), p.79-90

2019

Volltextzugriff (PDF)

High Ki-67 expression in involved bone marrow predicts worse clinical outcome in diffuse large B cell lymphoma patients treated with R-CHOP therapy

International journal of hematology, 2015-02, Vol.101 (2), p.140-147

2015

Volltextzugriff (PDF)

Prognostic value of Waldeyer’s ring involvement of diffuse large B-cell lymphoma treated with R-CHOP

International journal of hematology, 2013-03, Vol.97 (3), p.397-402

2013

Volltextzugriff (PDF)

Clinical importance of Bcl-6-positive non-deep-site involvement in non-HIV-related primary central nervous system diffuse large B-cell lymphoma

Journal of neuro-oncology, 2011-09, Vol.104 (3), p.825-831

2011

Volltextzugriff (PDF)

Is there role of additional chemotherapy after definitive local treatment for stage I/II marginal zone lymphoma?: Consortium for Improving Survival of Lymphoma (CISL) study

International journal of hematology, 2015-10, Vol.102 (4), p.420-425

2015

Volltextzugriff (PDF)

Phase II study of ifosfamide, etoposide, and oxaliplatin (IFETOx) chemotherapy for relapsed or refractory non-Hodgkin’s lymphoma

International journal of hematology, 2013-11, Vol.98 (5), p.543-548

2013

Volltextzugriff (PDF)

Sequential eradication of Helicobacter pylori as a treatment for immune thrombocytopenia in patients with moderate thrombocytopenia: a multicenter prospective randomized phase 3 study

Annals of hematology, 2022-07, Vol.101 (7), p.1435-1445

2022

Volltextzugriff (PDF)

Alemtuzumab plus CHOP as front-line chemotherapy for patients with peripheral T-cell lymphomas : a phase II study

Cancer chemotherapy and pharmacology, 2007-06, Vol.60 (1), p.129-134

2007

Volltextzugriff (PDF)

Daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in Asian patients with newly diagnosed AL amyloidosis: subgroup analysis of ANDROMEDA

Annals of hematology, 2023-04, Vol.102 (4), p.863-876

2023

Volltextzugriff (PDF)

Therapeutic decision-making in elderly patients with acute myeloid leukemia: conventional intensive chemotherapy versus hypomethylating agent therapy

Annals of hematology, 2017-11, Vol.96 (11), p.1801-1809

2017

Volltextzugriff (PDF)

Response to hypomethylating agents improves long-term outcomes for lower-risk patients with myelodysplastic syndrome in case-matched cohorts

Annals of hematology, 2018-12, Vol.97 (12), p.2309-2317

2018

Volltextzugriff (PDF)

1 – 25 von 103

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLINK Contemporary (Konsortium Baden-Württemberg)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(103)

Publikationsform

Artikel
(103)

Sprache

Englisch
(103)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Automatic anomaly detection in engineering diagrams using machine learning

Variation in Summer Surface Air Temperature over Northeast Asia and Its Associated Circulation Anomalies

Poor prognostic impact of high serum ferritin levels in patients with a lower risk of diffuse large B cell lymphoma

Autologous stem cell transplantation in elderly patients with multiple myeloma in Korea: the KMM1807 study

Real-world toxicity and effectiveness of ixazomib, lenalidomide, and dexamethasone in Korean patients with relapsed and/or refractory multiple myeloma

Pegteograstim prophylaxis for chemotherapy-induced neutropenia and febrile neutropenia: a prospective, observational, postmarketing surveillance study in Korea

Clinical significance of metabolic tumor volume by PET/CT in stages II and III of diffuse large B cell lymphoma without extranodal site involvement

Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone

Phase II study of safety and efficacy of BEB (bendamustine, etoposide, and busulfan) conditioning regimen for autologous stem cell transplantation in non-Hodgkin lymphoma

Efficacy and safety of blinatumomab treatment in adult Korean patients with relapsed/refractory acute lymphoblastic leukemia on behalf of the Korean Society of Hematology ALL Working Party

A risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score

Clinical features and treatment outcomes of limited-stage mantle cell lymphoma: Consortium for Improving Survival of Lymphoma report

Different prognostic effects of core-binding factor positive AML with Korean AML registry data

The effectiveness and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world clinical practice: a study of the Korean Multiple Myeloma Working Party (KMMWP-151 study)

Venous thromboembolism in relapsed or refractory multiple myeloma patients treated with lenalidomide plus dexamethasone

High Ki-67 expression in involved bone marrow predicts worse clinical outcome in diffuse large B cell lymphoma patients treated with R-CHOP therapy

Prognostic value of Waldeyer’s ring involvement of diffuse large B-cell lymphoma treated with R-CHOP

Clinical importance of Bcl-6-positive non-deep-site involvement in non-HIV-related primary central nervous system diffuse large B-cell lymphoma

Is there role of additional chemotherapy after definitive local treatment for stage I/II marginal zone lymphoma?: Consortium for Improving Survival of Lymphoma (CISL) study

Phase II study of ifosfamide, etoposide, and oxaliplatin (IFETOx) chemotherapy for relapsed or refractory non-Hodgkin’s lymphoma

Sequential eradication of Helicobacter pylori as a treatment for immune thrombocytopenia in patients with moderate thrombocytopenia: a multicenter prospective randomized phase 3 study

Alemtuzumab plus CHOP as front-line chemotherapy for patients with peripheral T-cell lymphomas : a phase II study

Daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in Asian patients with newly diagnosed AL amyloidosis: subgroup analysis of ANDROMEDA

Therapeutic decision-making in elderly patients with acute myeloid leukemia: conventional intensive chemotherapy versus hypomethylating agent therapy

Response to hypomethylating agents improves long-term outcomes for lower-risk patients with myelodysplastic syndrome in case-matched cohorts

Aktive Filter

Suchergebnisse filtern